Retour
44
Fourchette du Jour
17,65 €
18,60 €
Fourchette 52 Semaines
16,76 €
28,75 €
Volume
2 116 522
Moyenne 50J / 200J
21,58 €
/
22,49 €
Clôture Précédente
18,13 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 25,2 | 0,4 |
| P/B | 2,9 | 2,9 |
| ROE % | 12,5 | 3,8 |
| Net Margin % | 4,5 | 3,9 |
| Rev Growth 5Y % | 26,7 | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Revenue grew 26,67% annually over 5 years — strong growth
ROE of 12,48% — decent returns on equity
Debt/Equity of 0,05 — conservative balance sheet
Generating 191,78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 16,27%
Cash machine — converts 327,72% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
26,67%
Revenue (1Y)10,40%
Earnings (1Y)7,70%
FCF Growth (3Y)1,77%
Qualité
Return on Equity
12,48%
ROIC11,84%
Net Margin4,54%
Op. Margin6,62%
Sécurité
Debt / Equity
0,05
Current Ratio2,73
Interest Coverage0,00
Valorisation
P/E Ratio
25,21
P/B Ratio2,86
EV/EBITDA16,26
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,40% | Revenue Growth (3Y) | 8,80% |
| Earnings Growth (1Y) | 7,70% | Earnings Growth (3Y) | -2,88% |
| Revenue Growth (5Y) | 26,67% | Earnings Growth (5Y) | -2,88% |
| Profitability | |||
| Revenue (TTM) | 1,29B | Net Income (TTM) | 58,52M |
| ROE | 12,48% | ROA | 7,88% |
| Gross Margin | 23,63% | Operating Margin | 6,62% |
| Net Margin | 4,54% | Free Cash Flow (TTM) | 191,78M |
| ROIC | 11,84% | FCF Growth (3Y) | 1,77% |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 2,73 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 25,21 | P/B Ratio | 2,86 |
| P/S Ratio | 1,14 | PEG Ratio | 2,45 |
| EV/EBITDA | 16,26 | Dividend Yield | 0,00% |
| Market Cap | 1,48B | Enterprise Value | 1,39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,29B | 1,17B | 1,09B | 786,91M | 500,62M |
| Net Income | 58,52M | 54,34M | 62,04M | 30,36M | 65,77M |
| EPS (Diluted) | 0,65 | 0,57 | 0,62 | 0,30 | 0,66 |
| Gross Profit | 304,48M | 253,36M | 238,80M | 167,33M | 112,14M |
| Operating Income | 85,28M | 67,46M | 62,18M | 23,34M | 32,34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 742,44M | 607,10M | 756,62M | 542,99M | 358,07M |
| Total Liabilities | 226,39M | 185,04M | 203,19M | 166,02M | 106,24M |
| Shareholders' Equity | 516,04M | 422,06M | 553,43M | 376,97M | 251,82M |
| Total Debt | 24,00M | 19,27M | 19,39M | 7,71M | 8,65M |
| Cash & Equivalents | 112,24M | 162,31M | 97,30M | 120,08M | 91,41M |
| Current Assets | 551,78M | 472,72M | 640,41M | 433,86M | 258,54M |
| Current Liabilities | 202,39M | 168,63M | 185,95M | 159,54M | 98,82M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#529 of 1021
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026